ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
48
views
0
references
Top references
cited by
54
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,974
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study
Author(s):
F Milanetti
,
J Bucha
,
James A. Russell
,
Borko Jovanovic
,
J C Voltarelli
,
Cheryl Loh
,
John W. Burns
,
Alessandro Testori
,
Yu Oyama
,
Jessica Stern
,
Paolo A. Muraro
,
John W. Rose
,
Charles Burt
,
Dusan Stefosky
,
Bruce Cohen
,
George Katsamakis
,
Jan Storek
,
Roumen Balabanov
,
Dusan Stefoski
Publication date:
2009-03-01
Journal:
The Lancet. Neurology
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Further versions
oa repository (via OAI-PMH doi match)
Powered by
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
NTT Journal for Theology and the Study of Religion
Author and article information
Journal
DOI::
10.1016/S1474-4422(09)70017-1
License:
http://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,974
Citrulline: a potentially simple quantitative marker of intestinal epithelial damage following myeloablative therapy.
Authors:
L Lutgens
,
N Blijlevens
,
J Donnelly
…
Clinical and radiological control of highly active relapsing-remitting multiple sclerosis with first-line natalizumab
Authors:
Jose Eustasio Meca-Lallana
,
Jose L. Diaz-Perez
,
Adelaida Leon-Hernández
…
Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia
Authors:
Mai F. Alsaqa’aby
,
Varun Vaidya
,
Noura Khreis
…
See all similar
Cited by
53
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Authors:
Paolo A. Muraro
,
Roland Martin
,
Giovanni Mancardi
…
Cell-based therapeutic strategies for multiple sclerosis
Authors:
Neil Scolding
,
Marcelo C. Pasquini
,
Stephen C Reingold
…
High-dose immunosuppressive therapy and autologous HCT for relapsing-remitting MS
Authors:
Richard Nash
,
George Hutton
,
Michael K. Racke
…
See all cited by
Version 1
Version 1